端粒酶逆转录酶
皮调节素
端粒酶
生物
永生化细胞系
分子生物学
细胞培养
基因表达
癌变
互补DNA
癌症研究
基因
遗传学
表皮生长因子
安非雷古林
作者
Charlotta Lindvall,Mi Hou,Toshi Komurasaki,Chengyun Zheng,Marie Arsenian‐Henriksson,John M. Sedivy,Magnus Björkholm,Bin Tean Teh,Magnus Nordenskjöld,Dawei Xu
出处
期刊:PubMed
日期:2003-04-15
卷期号:63 (8): 1743-7
被引量:100
摘要
Reconstitution of telomerase activity by ectopic expression of telomerase reverse transcriptase (hTERT) results in an immortal phenotype in various types of normal human cells, including fibroblasts. Despite lack of transformation characteristics, it is unclear whether hTERT-immortalized cells are physiologically and biochemically the same as their normal counterparts. Here, we compared the gene expression profiles of normal and hTERT-immortalized fibroblasts by using a cDNA microarray containing 20,736 cDNA clones and identified 172 dysregulated genes or expressed sequence tags (ESTs). One of the highly expressed genes in the hTERT-immortalized fibroblasts (hTERT-BJ cells) encodes epiregulin, a potent growth factor. Blockade of epiregulin reduced the growth of hTERT-BJ cells and colony formation of hTERT-transformed fibroblasts. Moreover, inhibition of epiregulin function in immortal hTERT-BJ cells triggered a senescence program. Our results suggest that both activation of telomerase and subsequent induction of epiregulin are required for sustained cell proliferation. Given the significant difference in gene expression profiles between normal and hTERT-immortalized fibroblasts and the close relationship between epiregulin and tumorigenesis, we conclude that hTERT-immortalized cells may not replace their normal counterparts for studies of normal cell biology and that the use of hTERT for expansion of normal human cells for therapeutic purposes must be approached with caution.
科研通智能强力驱动
Strongly Powered by AbleSci AI